Ex-Eli Lil­ly ex­ec Azar lands HHS nom­i­na­tion as Trump cham­pi­ons low­er drug prices

Pres­i­dent Don­ald Trump may oc­ca­sion­al­ly erupt with pas­sion­ate crit­i­cism for bio­phar­ma com­pa­nies and the ex­ecs who run them, but once again he’s go­ing with an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER